<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(12)</volume><submitter>Mehmood H</submitter><pubmed_abstract>A novel series of fluorophenyl-based thiazoles was synthesized following the Hanztsch method. All of the compounds were initially verified with physical parameters (color, melting point, retardation factor (&lt;i>R&lt;/i> &lt;sub>f&lt;/sub>)), which were further confirmed by several spectroscopic methods, including ultraviolet-visible (UV-visible), Fourier-transform infrared (FTIR), &lt;sup>1&lt;/sup>H, &lt;sup>13&lt;/sup>C, &lt;sup>19&lt;/sup>F NMR, and high-resolution mass spectrometry (HRMS). The binding interactions of all compounds were studied using a molecular docking simulation approach. Furthermore, each compound was evaluated for its alpha(α)-amylase, antiglycation, and antioxidant potentials. The biocompatibility of all compounds was checked with an &lt;i>in vitro&lt;/i> hemolytic assay. All synthesized scaffolds </pubmed_abstract><journal>ACS omega</journal><pagination>11433-11446</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10061536</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Synthesis of Fluorinated Hydrazinylthiazole Derivatives: A Virtual and Experimental Approach to Diabetes Management.</pubmed_title><pmcid>PMC10061536</pmcid><pubmed_authors>Perveen S</pubmed_authors><pubmed_authors>Akhtar T</pubmed_authors><pubmed_authors>Orfali R</pubmed_authors><pubmed_authors>Khalid M</pubmed_authors><pubmed_authors>Mehmood H</pubmed_authors><pubmed_authors>Haroon M</pubmed_authors><pubmed_authors>Woodward S</pubmed_authors><pubmed_authors>Asghar MA</pubmed_authors><pubmed_authors>Baby R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synthesis of Fluorinated Hydrazinylthiazole Derivatives: A Virtual and Experimental Approach to Diabetes Management.</name><description>A novel series of fluorophenyl-based thiazoles was synthesized following the Hanztsch method. All of the compounds were initially verified with physical parameters (color, melting point, retardation factor (&lt;i>R&lt;/i> &lt;sub>f&lt;/sub>)), which were further confirmed by several spectroscopic methods, including ultraviolet-visible (UV-visible), Fourier-transform infrared (FTIR), &lt;sup>1&lt;/sup>H, &lt;sup>13&lt;/sup>C, &lt;sup>19&lt;/sup>F NMR, and high-resolution mass spectrometry (HRMS). The binding interactions of all compounds were studied using a molecular docking simulation approach. Furthermore, each compound was evaluated for its alpha(α)-amylase, antiglycation, and antioxidant potentials. The biocompatibility of all compounds was checked with an &lt;i>in vitro&lt;/i> hemolytic assay. All synthesized scaffolds </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Mar</publication><modification>2025-04-05T13:22:03.456Z</modification><creation>2025-04-05T13:22:03.456Z</creation></dates><accession>S-EPMC10061536</accession><cross_references><pubmed>37008089</pubmed><doi>10.1021/acsomega.3c00265</doi></cross_references></HashMap>